Where does Redx Pharma PLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Redx Pharma PLC ranks #19,077 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Redx Pharma PLC hold?

Redx Pharma PLC holds 15 US utility patents granted between 2017 and 2025, spanning 4 technology areas.

What is Redx Pharma PLC's Innovation Score?

Redx Pharma PLC has an Innovation Score of 32.7 out of 100 (42nd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Redx Pharma PLC focus on?

Redx Pharma PLC's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 15 patents, ranking #1,291 of 6,058 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

Is Redx Pharma PLC's patent grant rate increasing or decreasing?

Redx Pharma PLC's recent grant velocity is -25% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Redx Pharma PLC's patents?

Redx Pharma PLC's patents average 19.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Redx Pharma PLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Redx Pharma PLC

USPTO PatentsView assignee record - 15 granted patents across 4 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Redx ranks #19,077 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 4 technology areas.

#19,077
of 49,997 US assignees by volume: 42nd percentile
by Innovation Score (32.7/100): 19.4
avg claims per patent: -25%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R19077 · Foreign Corporation #19,077 · 15 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 15 grants
MID-PACK #19,077/49,997
PHOTO-FINISH Rave Wireless
CPC-NARROW A61P · 4 areas
INNOV-THIN 32.7/100
CLAIMS-RICH 19.4 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -25% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Rave Wireless, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Redx’s 32.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.6 pts (29%) Velocity 4.4 pts (13%) Breadth 7.1 pts (22%) Claim depth 11.6 pts (35%)

Qualcomm Incorporated · highest

85
BroadPak · near

33
Innovative Sonic · near

33
Redx Pharma · this assignee

33
DePuy International · near

33
Yokogawa Test &… · near

33
3D Lighting… · lowest

7

What this shows Redx's Innovation Score is 32.7/100 (42nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Redx?

Each dot is one of Redx’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Redx’s own 19.4 claims/patent is ABOVE the 17.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Redx vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Redx's grants concentrate

Redx Pharma PLC is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2019 (4 grants) versus a trough of 1 in 2018. By volume, Redx sits between Rave Wireless, Inc. and Resodyn Corporation.

Redx's three-year grant acceleration

Redx Pharma PLC shows 4 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Rave Wireless

15
Raytheon Systems

15
Rebound

15
Red Tail Hawk

15
Rememdia LC

15
Resmed Asia Pte

15
Research & Design…

15
Resodyn

15
Redx Pharma ◀

15

What this shows Redx holds 15 patents at rank #19,089, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Redx

By rank, the assignees closest to #19,089 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Redx's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Redx, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Redx ranks #1,291 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (33 here).

BroadPak Corporation 33 Innovative Sonic Corporation 33 Yokogawa Test & Measurement Corporation 33 DePuy International Limited 33

Redx's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

33 42nd percentile higher than 42% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Redx Pharma PLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	3	20.0%
2018	1	6.7%
2019	4	26.7%
2020	2	13.3%
2022	2	13.3%
2023	1	6.7%
2024	1	6.7%
2025partial year	1	6.7%

Which technologies does Redx Pharma PLC patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 15

C07D - Heterocyclic Compounds 15

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 15

Y02A - Technologies FOR Adaptation TO Climate Change 2

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Redx Pharma PLC's patent record in context - here's where to go next.

Redx Pharma PLC's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #19,077 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Redx Pharma PLC against Rave Wireless, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 32.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.